Steve K Singh1, Michael A Borger
1Division of Cardiovascular Surgery, Toronto General Hospital, Toronto, Canada.
Percutaneous catheter-based valve interventions show promise for high-risk patients with valvular heart disease. Continued technological development and clinical trials are essential for widespread adoption and defining patient suitability.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: